508 related articles for article (PubMed ID: 25410860)
1. A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets.
Baz M; Paskel M; Matsuoka Y; Zengel J; Cheng X; Treanor JJ; Jin H; Subbarao K
J Virol; 2015 Feb; 89(3):1652-9. PubMed ID: 25410860
[TBL] [Abstract][Full Text] [Related]
2. A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
Baz M; Paskel M; Matsuoka Y; Zengel JR; Cheng X; Treanor JJ; Jin H; Subbarao K
J Virol; 2015 Jul; 89(13):6907-17. PubMed ID: 25903333
[TBL] [Abstract][Full Text] [Related]
3. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
[TBL] [Abstract][Full Text] [Related]
4. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
Min JY; Vogel L; Matsuoka Y; Lu B; Swayne D; Jin H; Kemble G; Subbarao K
J Virol; 2010 Nov; 84(22):11950-60. PubMed ID: 20810733
[TBL] [Abstract][Full Text] [Related]
5. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L
Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel equine influenza virus live-attenuated vaccine.
Rodriguez L; Reedy S; Nogales A; Murcia PR; Chambers TM; Martinez-Sobrido L
Virology; 2018 Mar; 516():76-85. PubMed ID: 29331866
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets.
Chen GL; Lamirande EW; Cheng X; Torres-Velez F; Orandle M; Jin H; Kemble G; Subbarao K
J Virol; 2014 Mar; 88(5):2867-76. PubMed ID: 24371061
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of live attenuated influenza a virus h6 vaccines in mice and ferrets.
Chen Z; Santos C; Aspelund A; Gillim-Ross L; Jin H; Kemble G; Subbarao K
J Virol; 2009 Jan; 83(1):65-72. PubMed ID: 18945773
[TBL] [Abstract][Full Text] [Related]
9. Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine.
Nogales A; Rodriguez L; Chauché C; Huang K; Reilly EC; Topham DJ; Murcia PR; Parrish CR; Martínez-Sobrido L
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928017
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of equine influenza vaccines for protection against A/Equine/Jilin/89 (H3N8)--a new equine influenza virus.
Webster RG; Thomas TL
Vaccine; 1993; 11(10):987-93. PubMed ID: 8212831
[TBL] [Abstract][Full Text] [Related]
11. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of inactivated equine influenza (H3N8) virus vaccine in murine model.
Pavulraj S; Virmani N; Bera BC; Joshi A; Anand T; Virmani M; Singh R; Singh RK; Tripathi BN
Vet Microbiol; 2017 Oct; 210():188-196. PubMed ID: 29103691
[TBL] [Abstract][Full Text] [Related]
13. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.
Suguitan AL; McAuliffe J; Mills KL; Jin H; Duke G; Lu B; Luke CJ; Murphy B; Swayne DE; Kemble G; Subbarao K
PLoS Med; 2006 Sep; 3(9):e360. PubMed ID: 16968127
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a novel cold-adapted modified-live equine influenza virus vaccine.
Tabynov K; Kydyrbayev Z; Ryskeldinova S; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
Aust Vet J; 2014 Nov; 92(11):450-7. PubMed ID: 25348146
[TBL] [Abstract][Full Text] [Related]
15. Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.
Isakova-Sivak I; de Jonge J; Smolonogina T; Rekstin A; van Amerongen G; van Dijken H; Mouthaan J; Roholl P; Kuznetsova V; Doroshenko E; Tsvetnitsky V; Rudenko L
PLoS One; 2014; 9(7):e102339. PubMed ID: 25058039
[TBL] [Abstract][Full Text] [Related]
16. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
Paillot R; Grimmett H; Elton D; Daly JM
Vet Res; 2008; 39(3):21. PubMed ID: 18252187
[TBL] [Abstract][Full Text] [Related]
17. Pathological and immunological protection induced by inactivated reverse genetics-based H3N8 equine influenza vaccine candidate in murine model.
Kumar R; Gupta RP; Bera BC; Anand T; Bhatia S; Kumar N; Sood R; Pavulraj S; Mathew MK; Balena V; Karthik S; Sansanwal R; Tripathi BN; Virmani N
Acta Virol; 2020; 64(3):359-374. PubMed ID: 32985215
[TBL] [Abstract][Full Text] [Related]
18. A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.
Joseph T; McAuliffe J; Lu B; Vogel L; Swayne D; Jin H; Kemble G; Subbarao K
Virology; 2008 Aug; 378(1):123-32. PubMed ID: 18585748
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
[TBL] [Abstract][Full Text] [Related]
20. A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus.
Blanco-Lobo P; Rodriguez L; Reedy S; Oladunni FS; Nogales A; Murcia PR; Chambers TM; Martinez-Sobrido L
Viruses; 2019 Oct; 11(10):. PubMed ID: 31614538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
